This inventor holds 1 USPTO granted patent. Top assignee: Praecis Pharmaceuticals, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Farah Natoli: Innovator in Peptide Compounds
Introduction
Farah Natoli is a notable inventor based in Quincy, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of peptide compounds that have therapeutic applications.
Latest Patents
Farah Natoli holds a patent for "Peptide compounds useful for modulating FGF receptor activity." This invention provides peptide compounds that bind to either a fibroblast growth factor (FGF) or a fibroblast growth factor receptor (FGFR), thereby modulating FGFR activity. The patent specifically focuses on FGFR2-IIIC and basic FGF. The peptide compound comprises an amino acid sequence: (Y/F)-(L/F/I)-(R/D/E/S/Y/G)-(Q/L/Y)-Y-(M/L/K/R)-(L/M/D/E/N/S)-(R/L/S/T)-(L/F/M/V) (SEQ ID NO: 1). Additionally, the invention includes pharmaceutical compositions containing these peptide compounds and methods for modulating FGFR activity.
Career Highlights
Farah Natoli is currently associated with Praecis Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has the potential to impact various therapeutic areas, particularly those related to growth factor signaling.
Collaborations
Farah collaborates with talented individuals such as Howard Benjamin and Ling Chai, who contribute to her innovative projects and research initiatives.
Conclusion
Farah Natoli's work in peptide compounds exemplifies the intersection of innovation and biotechnology. Her contributions are paving the way for new therapeutic strategies in modulating growth factor receptor activity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile